KYTX — KYVERNA THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in KYVERNA THERAPEUTICS INC (KYTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2024 Q1)
Avg. % of fund
0.01%
First filed
2024 Q1
Last filed
2025 Q2
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 1,700 -384 -18.4% 0.00% $5K $3.07
2025 Q1 ADDED 2,084 +1,116 +115.3% 0.00% $4K $1.93
2024 Q3 REDUCED 968 -59,832 -98.4% 0.00% $5K $4.89
2024 Q1 INITIATED 60,800 — — 0.05% $1.5M —
% of Fund (quarterly)    KYTX price (monthly, adj. close)

Other funds also holding KYTX

As of 2025 Q4 — sorted by position size

GordonMD Global Investments LP 29.6% Propel Bio Management, LLC 5.35% CAXTON CORP 3Y 7Y 4.12% AIGH Capital Management LLC 3Y 3.41% Bain Capital Life Sciences Investors, LLC 3Y 7Y 2.24% GILEAD SCIENCES, INC. 2.0% Monashee Investment Management LLC 3Y 7Y 1.03% HEIGHTS CAPITAL MANAGEMENT, INC 0.92% Insight Holdings Group, LLC 3Y 7Y 0.7% MBB PUBLIC MARKETS I LLC 3Y 0.6%
← Back to Point72 (DIFC) Ltd Holdings